Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
Resources
Report | 2022
Harm reduction, Substitution/OAT, Policy/Regulatory, Advocacy
We aimed to test the hypothesis that in-jail MOUD is associated with lower overdose mortality risk post-release.
Original research | 2022
Substitution/OAT, Legal system/law enforcement, Outcomes, Overdose, Mortality
Infographic | 2022
About pharmacists, Wrap-around services, Safer supply, Policy/Regulatory
Due to the coronavirus disease 2019 (COVID-19) pandemic, Health Canada issued an exemption to the Controlled Drugs and Substances Act (CDSA) on March 19, 2020, enabling pharmacists to act as prescr
Original research | 2022
About pharmacists, Policy/Regulatory, Wrap-around services, Safer supply
This research brief describes the first Extension for Community Healthcare Outcomes (ECHO) program focused on first responders and opioids, including the content covered and concomitant popularity
Original research | 2022
Overdose, Social services
The objective of this study was to identify patient and prescription characteristics associated with long-term buprenorphine treatment retention.
Original research | 2022
Substitution/OAT, About PWUD, Barriers and enablers, Outcomes
In order to expand the field’s understanding of care beyond an avowed a-political approach to clinical supervision, we conducted qualitative interviews with staff at Sydney Medically Supervised Inj
Original research | 2022
Overdose, SCS/OPS
Analysis of the UK Government’s 10-Year Drugs Strategy—a resource for practitioners and policymakers
Commentary | 2022
Policy/Regulatory
Commentary | 2022
About PWUD, Social services, Barriers and enablers, Housing, Youth
We examined how age-related patterns of cocaine and methamphetamine use vary by sexual identity and gender among a national sample.
Original research | 2022
About PWUD, Illegal drugs, 2SLGBTQI+, Stimulants
This study identified patient clinical and sociodemographic characteristics, and, more originally, service use patterns as predictors of death from physical illness or accidental/intentional causes
Original research | 2022
Mortality, About PWUD
This review aimed to assess the application and effectiveness of digital interventions to treat opioid use disorder globally.
Lit review | 2022
Digital health, About PWUD
Guide or handbook | 2021
SCS/OPS, Harm reduction, Policy/Regulatory, Illegal drugs
Commentary | 2022
About PWUD, Barriers and enablers
Racial/ethnic minoritized patients are less likely to receive OAT compared to non-Hispanic White patients.
Original research | 2022
Equity, Barriers and enablers, About PWUD, Substitution/OAT
To understand patient experience of federal regulatory changes governing methadone and buprenorphine (MOUD) access in Arizona during the COVID-19 pandemic.
Original research | 2022
Policy/Regulatory, About PWUD, Substitution/OAT, Carries/take-home doses
Guidelines | 2022
About prescribers, Substitution/OAT, Hospitals, Clinical guidance
Safer Opioid Supply Program Protocols: Parkdale Queen West Community Health Centre, Toronto, Ontario
Guide or handbook | 2022
Clinical guidance, Harm reduction, Policy/Regulatory, Safer supply, About prescribers
